• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊使用广谱静脉抗生素治疗的患者发生细菌感染的可能性。

Likelihood of Bacterial Infection in Patients Treated With Broad-Spectrum IV Antibiotics in the Emergency Department.

机构信息

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.

出版信息

Crit Care Med. 2021 Nov 1;49(11):e1144-e1150. doi: 10.1097/CCM.0000000000005090.

DOI:10.1097/CCM.0000000000005090
PMID:33967206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8516665/
Abstract

OBJECTIVES

Best practice guidelines and quality metrics recommend immediate antibiotic treatment for all patients with suspected sepsis. However, little is known about how many patients given IV antibiotics in the emergency department are ultimately confirmed to have bacterial infection.

DESIGN, SETTING, AND PATIENTS: We performed a retrospective study of adult patients who presented to four Massachusetts emergency departments between June 2015 and June 2018 with suspected serious bacterial infection, defined as blood cultures drawn and broad-spectrum IV antibiotics administered. Structured medical record reviews were performed on a random sample of 300 cases to determine the post hoc likelihood of bacterial infection, categorized as definite, likely, unlikely, or definitely none.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Among the 300 patients with suspected serious bacterial infections, mean age was 68 years (sd 18), median hospital length of stay was 5 days (interquartile range, 3-8 d), 45 (15%) were admitted directly to ICU, and 14 (5%) died in hospital. Overall, 196 (65%) had definite (n = 115; 38%) or likely (n = 81; 27%) bacterial infection, whereas 104 (35%) were unlikely (n = 55; 18%) or definitely not infected (n = 49; 16%). Antibiotic treatment durations differed by likelihood of infection (median 15 days for definite, 9 for likely, 7 for unlikely, and 3 for definitely not infected). The most frequent post hoc diagnoses in patients with unlikely or definitely no bacterial infection included viral infections (28%), volume overload or cardiac disease (9%), drug effects (9%), and hypovolemia (7%). The likelihoods of infection were similar in the subset of 96 cases in whom emergency department providers explicitly documented possible or suspected sepsis and in the 45 patients admitted from the emergency department to the ICU.

CONCLUSIONS

One third of patients empirically treated with broad-spectrum antibiotics in the emergency department are ultimately diagnosed with noninfectious or viral conditions. These findings underscore the difficulty diagnosing serious infections in the emergency department and have important implications for guidelines and quality measures that compel immediate empiric antibiotics for all patients with possible sepsis.

摘要

目的

最佳实践指南和质量指标建议对所有疑似脓毒症患者立即进行抗生素治疗。然而,对于在急诊科给予静脉抗生素的患者中,有多少最终被确诊为细菌感染,人们知之甚少。

设计、地点和患者:我们对 2015 年 6 月至 2018 年 6 月期间在马萨诸塞州四家急诊科就诊的疑似严重细菌感染的成年患者进行了回顾性研究,这些患者的定义为抽取血培养并给予广谱静脉抗生素。我们对 300 例随机病例进行了结构化病历回顾,以确定细菌感染的后验可能性,分为明确、可能、不太可能或肯定没有。

干预措施

无。

测量和主要结果

在 300 例疑似严重细菌感染的患者中,平均年龄为 68 岁(标准差 18 岁),中位住院时间为 5 天(四分位间距,3-8 天),45 例(15%)直接收入 ICU,14 例(5%)住院期间死亡。总体而言,196 例(65%)有明确(n=115;38%)或可能(n=81;27%)的细菌感染,而 104 例(35%)不太可能(n=55;18%)或肯定没有感染(n=49;16%)。抗生素治疗时间因感染可能性而异(明确诊断的中位数为 15 天,可能为 9 天,不太可能为 7 天,肯定没有感染为 3 天)。在不太可能或肯定没有细菌感染的患者中,最常见的后验诊断包括病毒感染(28%)、容量超负荷或心脏疾病(9%)、药物作用(9%)和低血容量(7%)。在急诊科医生明确记录可能或疑似脓毒症的 96 例病例亚组和从急诊科转入 ICU 的 45 例患者中,感染的可能性相似。

结论

在急诊科接受广谱抗生素经验性治疗的患者中,有三分之一最终被诊断为非传染性或病毒性疾病。这些发现强调了在急诊科诊断严重感染的困难,对那些强制对所有疑似脓毒症患者立即使用经验性抗生素的指南和质量措施具有重要意义。

相似文献

1
Likelihood of Bacterial Infection in Patients Treated With Broad-Spectrum IV Antibiotics in the Emergency Department.急诊使用广谱静脉抗生素治疗的患者发生细菌感染的可能性。
Crit Care Med. 2021 Nov 1;49(11):e1144-e1150. doi: 10.1097/CCM.0000000000005090.
2
Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.降钙素原检测用于指导重症监护环境中脓毒症治疗及急诊科环境中疑似细菌感染治疗的抗生素疗法:一项系统评价与成本效益分析
Health Technol Assess. 2015 Nov;19(96):v-xxv, 1-236. doi: 10.3310/hta19960.
3
Frequency of Antibiotic Overtreatment and Associated Harms in Patients Presenting With Suspected Sepsis to the Emergency Department: A Retrospective Cohort Study.急诊科疑似脓毒症患者抗生素过度治疗的频率及相关危害:一项回顾性队列研究
Clin Infect Dis. 2025 Jul 18;80(6):1197-1207. doi: 10.1093/cid/ciaf118.
4
Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use.培养证实的脓毒症中抗生素耐药病原体的流行情况以及与经验性抗生素使用不足和广谱相关的结局。
JAMA Netw Open. 2020 Apr 1;3(4):e202899. doi: 10.1001/jamanetworkopen.2020.2899.
5
Sepsis visits and antibiotic utilization in U.S. emergency departments*.美国急诊室的脓毒症就诊和抗生素使用情况*。
Crit Care Med. 2014 Mar;42(3):528-35. doi: 10.1097/CCM.0000000000000037.
6
Delayed Second Dose Antibiotics for Patients Admitted From the Emergency Department With Sepsis: Prevalence, Risk Factors, and Outcomes.急诊科收治的脓毒症患者延迟使用第二剂抗生素:患病率、危险因素及结局
Crit Care Med. 2017 Jun;45(6):956-965. doi: 10.1097/CCM.0000000000002377.
7
Microbiological outcomes and antibiotic overuse in Emergency Department patients with suspected sepsis.急诊科疑似脓毒症患者的微生物学结果与抗生素过度使用情况
Neth J Med. 2017 Jun;75(5):196-203.
8
A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin.一项在重症监护患者中进行的随机对照试验,比较了 7 天经验性抗生素治疗与 2 天治疗不明来源医院获得性感染的效果。
Health Technol Assess. 2012 Sep;16(36):i-xiii, 1-70. doi: 10.3310/hta16360.
9
Association between time to antibiotic and mortality in patients with suspected sepsis in the Emergency Department: post hoc analysis of the 1-BED randomized clinical trial.急诊科疑似脓毒症患者使用抗生素的时间与死亡率之间的关联:1-BED随机临床试验的事后分析
Eur J Emerg Med. 2025 Apr 1;32(2):109-115. doi: 10.1097/MEJ.0000000000001212. Epub 2024 Dec 23.
10
Impact of emergency medicine clinical pharmacist practitioner-driven sepsis antibiotic interventions.急诊医学临床药师实践驱动的脓毒症抗生素干预的影响。
Am J Emerg Med. 2024 Feb;76:24-28. doi: 10.1016/j.ajem.2023.11.012. Epub 2023 Nov 11.

引用本文的文献

1
Antibiotics for suspected sepsis: who and when?用于疑似脓毒症的抗生素:哪些人以及何时使用?
Intensive Care Med. 2025 May 19. doi: 10.1007/s00134-025-07940-y.
2
Decision analysis model of rapid versus deferred antibiotic initiation in patients with suspected sepsis in the emergency department.急诊科疑似脓毒症患者快速与延迟使用抗生素起始治疗的决策分析模型
Intensive Care Med. 2025 Apr 29. doi: 10.1007/s00134-025-07899-w.
3
Clinical Gestalt to Predict Bacterial Infection and Mortality in Emergency Department Patients: A Prospective Observational Study.
临床整体判断对急诊科患者细菌感染及死亡率的预测:一项前瞻性观察研究
J Gen Intern Med. 2025 Feb 26. doi: 10.1007/s11606-025-09440-7.
4
Association Between the Sequence of β-Lactam and Vancomycin Administration and Mortality in Patients With Suspected Sepsis.β-内酰胺类药物与万古霉素给药顺序与疑似脓毒症患者死亡率之间的关联
Clin Infect Dis. 2025 Apr 30;80(4):761-769. doi: 10.1093/cid/ciae599.
5
Sepsis: key insights, future directions, and immediate goals. A review and expert opinion.脓毒症:关键见解、未来方向和即刻目标。一篇综述和专家观点。
Intensive Care Med. 2024 Dec;50(12):2043-2049. doi: 10.1007/s00134-024-07694-z. Epub 2024 Nov 12.
6
Trends in Empiric Broad-Spectrum Antibiotic Use for Suspected Community-Onset Sepsis in US Hospitals.美国医院疑似社区获得性败血症经验性广谱抗生素使用趋势。
JAMA Netw Open. 2024 Jun 3;7(6):e2418923. doi: 10.1001/jamanetworkopen.2024.18923.
7
Carbapenem-resistant Gram-negative bacteria (CR-GNB) in ICUs: resistance genes, therapeutics, and prevention - a comprehensive review.重症监护病房中的耐碳青霉烯类革兰氏阴性菌(CR-GNB):耐药基因、治疗和预防——全面综述。
Front Public Health. 2024 Mar 27;12:1376513. doi: 10.3389/fpubh.2024.1376513. eCollection 2024.
8
Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation.验证SeptiCyte RAPID以区分脓毒症与非感染性全身炎症。
J Clin Med. 2024 Feb 20;13(5):1194. doi: 10.3390/jcm13051194.
9
Heterogeneity of Benefit from Earlier Time-to-Antibiotics for Sepsis.抗生素治疗时机提前对脓毒症获益的异质性。
Am J Respir Crit Care Med. 2024 Apr 1;209(7):852-860. doi: 10.1164/rccm.202310-1800OC.
10
Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.在按绩效付费和电子质量措施时代提高脓毒症治疗效果:IDSA/ACEP/PIDS/SHEA/SHM/SIDP 联合立场文件。
Clin Infect Dis. 2024 Mar 20;78(3):505-513. doi: 10.1093/cid/ciad447.